VERACYTE, INC.

VCYT
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001384101

Price chart

Open-market purchases and sales by VCYT insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 22, 20265:16 PM ETSep 21, 2026Leite JohnGlobal Chief Commercial OffSSaleCommon Stock−4.02K$40.00−$160.6K124.33K−3.1%SEC10b5-1
Sep 16, 20264:08 PM ETSep 14, 2026Holstein JensDirectorSSaleCommon Stock−5K$40.9494−$204.75K27.47K−15.4%SEC10b5-1
Sep 4, 20267:54 PM ETSep 4, 2026Febbo Phillip G.Chief Scientific & Med OfficerSSaleCommon Stock−13.11K$43.0519−$564.41K133.05K−9.0%SEC10b5-1
Sep 4, 20267:54 PM ETSep 4, 2026Chambers RebeccaChief Financial OfficerSSaleCommon Stock−3.65K$43.0981−$157.39K166.03K−2.2%SEC10b5-1
Sep 4, 20267:54 PM ETSep 4, 2026McGuire AnnieEVP, General CounselSSaleCommon Stock−3.25K$43.0891−$140.21K131.16K−2.4%SEC10b5-1

The largest institutional positions in VCYT at the end of Q2 2026.

Institutions holding VCYT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.13,486,437$792.06M0.01%+313,819+2.4%Added
FMR LLC7,702,746$452.38M0.02%−61,103−0.8%Reduced
Artisan Partners Limited Partnership5,538,404$325.27M0.53%+42,034+0.8%Added
VANGUARD PORTFOLIO MANAGEMENT LLC4,716,191$276.98M0.01%+271,461+6.1%Added
STATE STREET CORP4,698,128$275.95M0.01%−345,462−6.8%Reduced